Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

American Journal of Epidemiology

Volumn 159, Issue 12, 2004, Pages 1160-1167

  Coughlin, Steven S ^a   Calle, Eugenia E ^b   Teras, Lauren R ^b   Petrelli, Jennifer ^b   Thun, Michael J ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Dept of Epidemiol/Survlnc Res ^*  (United States)

Author keywords

Breast neoplasms; Cohort studies; Colonic neoplasms; Diabetes mellitus; Liver neoplasms; Obesity; Pancreatic neoplasms; Prostatic neoplasms

Indexed keywords

CANCER;

ADULT; ARTICLE; BLADDER CANCER; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; COLON CANCER; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS CANCER; PREDICTION; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; AGED; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; RISK FACTORS; UNITED STATES;

EID: 2942520997     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh161     Document Type: Article

References (65)

1. Will JC, Vinicor F, Calle EE. Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 1999;10:313-18.
2. Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-14.
3. Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360-5.
4. Will JC, Galuska DA, Vinicor F, et al. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998;147:816-25.
5. Calle EE, Murphy TK, Rodriguez C, et al. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 1998;9:403-10.
6. Chow WH, Gridley G, Nyren O, et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 1995;87:930-1.
7. Ragozzino MW, Melton JM III, Chu CP, et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982;35:13-19.
8. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970;44:673-86.
9. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 1985;38: 435-41.
10. Koskinen SV, Reunanen AR, Martelin TP, et al. Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus. Am J Public Health 1998;88:765-70.
11. Ma J, Pollak MN, Giovannucci E, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 1999;91:620-5.
12. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000;183:1-9.
13. Giovannucci E. Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 1999;51(suppl 3):34-41.
14. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 1998;279:563-6.
15. Hankinson SE, Willett WC, Colditz GA, et al. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 1998;279:563-6.
16. Mantzoros CS, Tzonou A, Signorello LB, et al. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997;76:1115-18.
17. Wolk A, Mantzoros CS, Anderson SO, et al. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 1998;90:911-15.
18. Bohlke K, Cramer DW, Trichopoulos D, et al. Insulin-like growth factor-1 in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 1998;9:570-3.
19. Cohen P, Clemmons DR, Rosenfeld RG. Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 2000;10:297-305.
20. Shim M, Cohen P. IGFs and human cancer: implications regarding the risk of growth hormone therapy. Horm Res 1999; 51(suppl 3):42-51.
21. Giovannucci E, Rimm EB, Stampfer MJ, et al. Diabetes mellitus and risk of prostate cancer. Cancer Causes Control 1998;9: 3-9.
22. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993;137:235-41.
23. World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Vol 1. Geneva, Switzerland: World Health Organization, 1977.
24. Cox DR. Regression models and life tables (with discussion). J R Stat Soc (B) 1972;34:187-220.
25. La Vecchia C, D'Avanzo B, Negri E, et al. History of selected diseases and the risk of colorectal cancer. Eur J Cancer 1991; 27:582-6.
26. La Vecchia C, Negri E, Decarli A, et al. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997;6:1007-10.
27. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case-control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-404.
28. Hardell L, Fredrikson M, Axelson O. Case-control study on colon cancer regarding previous disease and drug intake. Int J Oncol 1996;8:439-44.
29. Le Marchand L, Wilkens LR, Kolonel LN, et al. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997;57: 4787-94.
30. Adami HO, Chow WH, Nyren O, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;88:1472-7.
31. Lawson DH, Gray JM, McKillop C, et al. Diabetes mellitus and primary hepatocellular carcinoma. Q J Med 1986;61:945-55.
32. La Vecchia C, Negri E, D'Avanzo B, et al. Medical history and primary liver cancer. Cancer Res 1990;50:6274-7.
33. La Vecchia C, Negri E, Franceschi S, et al. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994;70:950-3.
34. La Vecchia C, Negri E, Decarli A, et al. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997;73:204-7.
35. Yu MC, Tong MJ, Govindarajan S, et al. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
36. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
37. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995;273:1605-9.
38. Gapstur SM, Gann PH, Lowe W, et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000;283: 2552-8.
39. Smith GD, Egger M, Shipley MJ, et al. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 1992;136:1110-14.
40. Coughlin SS, Calle EE, Patel AV, et al. Predictors of mortality from pancreatic cancer among a large cohort of United States adults. Cancer Causes Control 2000;11:915-23.
41. Michaud DS, Giovannuci E, Willett WC, et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001;286:921-9.
42. Talamini R, Franceschi S, Favero A, et al. Selected medical conditions and risk of breast cancer. Br J Cancer 1997;75: 1699-703.
43. Adami HO, Rimsten A. Prevalence of hypertension and diabetes in breast cancer: a case-control study in 179 patients and age-matched, non-hospitalized controls. Clin Oncol 1978;4: 243-9.
44. Franceschi S, La Vecchia C, Negri E, et al. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990;26:781-5.
45. Kopp S, Tanneberger S, Mohner M, et al. Diabetes and breast cancer risk. Int J Cancer 1990;46:751-2.
46. Moseson M, Koenig GL, Shore RE, et al. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993;22:1000-9.
47. Goodman MT, Cologne JB, Moriwaki H, et al. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 1997;26:144-53.
48. Sellers TA, Anderson KE, Olson JE, et al. Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer. Epidemiology 1998;9:102-5.
49. Bruning PF, Bonfrer JM, van Noord PA, et al. Insulin resistance and breast-cancer risk. Int J Cancer 1992;52:511-16.
50. Del Giudice ME, Fantus IG, Ezzat S, et al. Insulin and related factors in premenopausal breast cancer risk. Br Cancer Res Treat 1998;47:111-20.
51. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol 1974;2:122-9.
52. Elwood JM, Cole P, Rothman KJ, et al. Epidemiology of endometrial cancer. J Natl Cancer Inst 1977;59:1055-60.
53. Parazzini F, La Vecchia C, Negri E, et al. Diabetes and endometrial cancer: an Italian case-control study. Int J Cancer 1999;81:539-42.
54. Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 1998;148:234-40.
55. Brinton LA, Berman ML, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 1992;167: 1317-25.
56. Terry P, Baron JA, Weiderpass E, et al. Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 1999;82:38-42.
57. Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol 2000;182:23-9.
58. Weiderpass E, Persson I, Adami HO, et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185-92.
59. Adler AI, Weiss NS, Kamb ML, et al. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States). Cancer Causes Control 1996;7: 475-8.
60. Schlehofer B, Pommer W, Mellemgaard A, et al. International renal-cell-cancer study. VI. The role of medical and family history. Int J Cancer 1996;66:723-6.
61. Mellemgaard A, Niwa S, Mehl ES, et al. Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 1994;23:923-30.
62. Kreiger N, Marrett LD, Dodds L, et al. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 1993;4:101-10.
63. Cerhan JR, Wasslace RB, Folsom AR, et al. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst 1997;89:314-18.
64. Gittelsohn A, Senning J. Studies on the reliability of vital and health records: I. Comparison of cause of death and hospital record diagnoses. Am J Public Health 1979;69:680-9.
65. Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981;71:242-50.